VTRS
NASDAQ · Pharmaceuticals
Viatris Inc
$17.10
+0.15 (+0.89%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
—
1Y
+74.67%
YTD
+37.24%
Open$16.98
Previous Close$16.95
Day High$17.35
Day Low$16.87
52W High$18.39
52W Low$9.43
Volume—
Avg Volume7.54M
Market Cap18.96B
P/E Ratio—
EPS$-0.36
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$13.14
Above
SMA 200
$10.55
Above
RSI (14)
87.6
Overbought
Trend
Golden Cross
Bullish
Analyst Ratings
Buy
17 analysts
Price Target
+618.2% upside
Current
$17.10
$17.10
Target
$122.82
$122.82
$69.38
$122.82 avg
$167.78
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 13.67B | 14.26B | 3.47B |
| Net Income | -3,359,009,661 | -3,155,645,819 | 966.90M |
| Profit Margin | -24.6% | -23.4% | 27.9% |
| EBITDA | 30.99M | 30.73M | 1.51B |
| Free Cash Flow | — | — | 925.81M |
| Rev Growth | -4.2% | -4.2% | -2.8% |
| Debt/Equity | 0.98 | 0.98 | 0.35 |
Dividend
Dividend Yield2.70%
Annual Dividend$0.48
Payout Ratio28.5%
Frequencyquarterly
Ex-Dividend—
Pay Date—
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,164.89 | +1.04% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.47 | -0.19% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $149.50 | +1.79% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $27.74 | +0.29% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $62.62 | -0.70% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $71.33 | -0.10% | 11.5 | 30.15B |